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SCIENTIFIC OPINION 
Guidance on the assessment of the toxigenic potential of Bacillus species 
used in animal nutrition
1† 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Bacillus species are used in animal production directly as microbial feed additives or as the source of other feed 
additives,  notably  enzymes.  The  principal  safety  concern  for  consumers  and,  to  a  lesser  extent  livestock, 
associated with Bacillus is a capacity for toxin production.  However, the capacity for toxin production and the 
nature of the toxins produced is unevenly distributed over the genus, occurring frequently in some species and 
more rarely in others. In principle, the selection of strains belonging to the B. cereus taxonomic group for direct 
use in animal production is considered inadvisable. If, however, they are proposed then the full genome should 
be  sequenced  and  a  bioinformatic  analysis  made  to  search  for  genes  coding  for  enterotoxins  and  cereulide 
synthase. If there is evidence of homology, the non-functionality of the genes (e.g. mutation, deletion) must be 
demonstrated.  For  other  species,  concerns  appear  to  be  associated  to  the  production  of  surfactin  like-
lipopeptides, although the relation between the presence of these compounds and/or other toxic factors and the 
risk of illness in human has not yet been established. In the absence of animal models shown to be able to 
distinguish hazardous from non hazardous strains, the FEEDAP Panel relies on the use of in vitro cell-based 
methods to detect evidence of a cytotoxic effect. Such tests should be made with culture supernatants since the 
concentration of cells obtained in a broth culture would always exceed that found in animal food products. If the 
strain proves to be cytotoxic it is not recommended for use.   
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SUMMARY 
The  European  Food  Safety  Authority  (EFSA)  asked  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) to update the FEEDAP Panel Guidance on the assessment 
of the toxigenic potential of Bacillus species used in animal nutrition published in 2011. 
Bacillus species are used in animal production directly as microbial feed additives or as the source of 
other feed additives, notably enzymes. The principal safety concern for consumers and, to a lesser 
extent livestock, associated with Bacillus is a capacity for toxin production.  However, the capacity for 
toxin  production  and  the  nature  of  the  toxins  produced  is  unevenly  distributed  over  the  genus, 
occurring frequently in some species and more rarely in others.  
In principle, the selection of strains belonging to the B. cereus taxonomic group for direct use in 
animal production is considered inadvisable. If, however, they are proposed then the full genome 
should be sequenced and a bioinformatic analysis made to search for genes coding for enterotoxins 
and cereulide synthase. If there is evidence of homology, the non-functionality of the genes (e.g. 
mutation, deletion) must be demonstrated.  
For other species, concerns appear to be associated to the production of surfactin like-lipopeptides, 
although the relation between the presence of these compounds and/or other toxic factors and the risk 
of illness in human has not yet been established. In the absence of animal models shown to be able to 
distinguish hazardous from non hazardous strains, the FEEDAP Panel relies on the use of in vitro cell-
based  methods  to  detect  evidence  of  a  cytotoxic  effect.  Such  tests  should  be  made  with  culture 
supernatants since the concentration of cells obtained in a broth culture would always exceed that 
found in animal food products. If the strain proves to be cytotoxic it is not recommended for use.   
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BACKGROUND AS PROVIDED BY EFSA  
Regulation  (EC)  No  1831/20031  establishes  the  rules  governing  the  Community  authorisation  of 
additives  for  use  in  animal  nutrition.  Moreover,  Article  7(6)  of  this  Regulation  provides  for  the 
European  Food  Safety  Authority  (EFSA)  to  publish  detailed  guidance  to  assist  applicants  in  the 
preparation and presentations of applications. 
EFSA has the responsibility to assess the safety of feed additives before an authorisation is granted. A 
considerable amount of feed additives are composed by microorganisms. As a tool to simplify and 
harmonise  within  EFSA  the  assessment  of  microorganisms  used  in  food  and  feed,  the  Scientific 
Committee published in 2007 one opinion on the introduction of a Qualified Presumption of Safety 
(QPS) approach for the assessment of selected microorganisms. 
The list of microorganisms included in such opinion and considered to qualify for the QPS approach to 
safety assessment is updated regularly by the Biological Hazards (BIOHAZ) Panel. The last update is 
from 2012. The QPS approach is regularly used by the Panel on Additives and Products or Substances 
used in Animal Feed (FEEDAP) in the assessment of microbial products subject to a pre-authorisation 
assessment. 
Bacillus species are widely used as feed additives, and several of them are considered to qualify for 
the  QPS  approach  to  safety  assessment,  provided  that  the  qualification  of  the  absence  of  food 
poisoning toxins, surfactant activity or enterotoxic activity is met. In 2000, the Scientific Committee 
for Animal Nutrition (SCAN) adopted an opinion on the safety of use of Bacillus species in animal 
nutrition. This opinion  was  revised  in  2011  by  the FEEDAP  Panel in  the  form  of  the Technical 
Guidance on the assessment of the toxigenic potential of Bacillus species used in animal nutrition 
(EFSA  FEEDAP  Panel,  2011),  and  updated according  to  the  most  recent  scientific  and technical 
developments.  The  aim  of  this  document,  which  complements  the  QPS  opinion,  is  to  provide 
applicants with proportionate and up-to-date guidance on how to conduct the safety assessment of 
Bacillus-based products. 
This Guidance makes a clear difference between the Bacillus cereus group (including known human 
enteropathogens) and other Bacillus species.  
Science evolves fast and since the Guidance document was issued, new information on the toxicity 
and prevalence of these toxins has become available. Therefore, the FEEDAP Panel in view of this 
and of the experience gained so far from the assessment of the toxigenic potential of products based on 
Bacillus  species  (other than  B.  cereus)  is intended  to  produce  an  update  of  the  Guidance  on  the 
assessment of the toxigenic potential of Bacillus species used in animal nutrition. This output is aimed 
at highlighting the uncertainties and making proposals to address them in the context of the assessment 
of the dossiers of non-Bacillus cereus based products.  
TERMS OF REFERENCE AS PROVIDED BY EFSA 
The FEEDAP Panel is requested to update the Guidance on the assessment of the toxigenic potential 
of Bacillus species used in animal nutrition. Guidance on Bacillus safety 
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1.  Introduction 
A number of strains of Bacillus species are used in animal production either directly as microbial feed 
additives or as the source of other feed additives, notably enzymes. Regulation (EC) No 1831/2003 
requires that all feed additives, including microorganisms, are assessed for safety before being placed 
on the market. The principal safety concern for consumers and, to a lesser extent livestock, associated 
with Bacillus (and related genera) is a capacity for toxin production. However, the capacity for toxin 
production is unevenly distributed over the genus, occurring frequently in some species and more 
rarely, if at all, in others. For this reason, the Scientific Committee on Animal Nutrition (SCAN), 
when first developing guidance in this area, recommended that the use of strains of the Bacillus cereus 
taxonomic  group,  a  group  containing  many  known  pathogenic  strains,  be  strongly  discouraged.  
However, the Committee recognised that strains from other Bacillus species may be considered safe 
(EC, 2000). The FEEDAP Panel concurs with this general position. 
The Qualified Presumption of Safety (QPS) approach to the safety assessment of microorganisms 
adopted by EFSA is considered applicable to most of the commercially relevant  Bacillus species 
(EFSA, 2007; EFSA BIOHAZ Panel, 2013). This approach requires the unambiguous identification of 
the strain being assessed, a demonstration of susceptibility to clinically relevant antibiotics and, in 
particular, evidence that the strain lacks a capacity for toxin production. Any other strain of Bacillus or 
related genera not falling within the scope of the QPS approach would also require an assessment of 
toxigenic potential. This document is intended to provide technical guidance for the assessment of any 
toxigenic potential for strains of Bacillus intended to be used directly as a feed additive or indirectly as 
a source of such additives. 
2.  The scope of the guidance 
Although a number of species earlier considered to belong to the genus Bacillus have been transferred 
to other genera, to date none has been the subject of a feed additive assessment. Since relatively little 
is  known  about  the  toxigenic  capacity  of  the  genera  related  to  Bacillus  (i.e.,  Geobacillus, 
Aneurinibacillus and Paenibacillus) and, consequently, whether the approach to safety assessment 
described  would  fully  apply,  it  is  considered  prudent  to  restrict  this  guidance  to  bacterial  strains 
belonging to Bacillus sensu strictu.  
3.  Safety concerns caused by Bacillus species 
3.1.  Identification 
Characterisation of Bacillus strains according to Claus and Berkeley (1986) and Bergey’s manual of 
Systematic Bacteriology (2009) must be completed by molecular methods to identify strains to the 
species level. This is essential as it determines whether the current guideline applies and, if so, the 
nature of the testing recommended. Partial sequences (approximately 500 bp) of the 16S rRNA gene 
can be amplified using methods described in Guinebretière et al. (2001) and From et al. (2005) and 
compared  to  sequences  from  databases.  If  the  partial  sequence  does  not  provide  a  definitive 
identification, then the 16S rRNA gene should be fully sequenced (Guinebretière et al., 2001). To 
differentiate species within the B. subtilis group, partial sequences of the gyrA gene or gyrB genes may 
be  needed  in  addition  to  the  16S  rRNA  gene  sequences.  These  can  be  obtained  using  methods 
described in Chun and Bae (2000) and From et al. (2005) for gyrA and Wang et al. (2007) for gyrB. 
3.2.  Assessment of Bacillus species other than the Bacillus cereus group 
Bacillus species other than members of the B. cereus group are a rare cause of foodborne diseases. In 
such events, the food contained high numbers (between 10
5 and 10
9 CFU/g) of the suspected Bacillus 
spp. (Kramer and Gilbert, 1989, From et al., 2007a). The production of the B. cereus-like diarrhoeal 
enterotoxins by some strains of other Bacillus species was described in the SCAN opinion (EC, 2000), 
although such strains have so far not been associated with foodborne diseases. The current view is that 
the very few reports of B. cereus–like enterotoxins occurring in other species of Bacillus are likely to 
have resulted from a misidentification of the strain involved (From et al., 2005). The few incidents of Guidance on Bacillus safety 
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food poisoning investigated where non-B. cereus group strains were determined to be the causative 
organism suggest an association with surfactin-like lipopeptides (From et al., 2007b). However, the 
capacity for cyclic lipopeptides production appears widely distributed, if not universal amongst strains 
of B. subtilis (Apetroaie-Constantin et al., 2009, From et al., 2007a, Hwang et al., 2009, Mikkola et 
al., 2007), B. licheniformis (Nieminen et al., 2007, Dybwad et al., 2013, Madslien et al., 2013), B. 
pumilus (Taylor et al., 2005, From et al., 2007b) and B. mojavensis (From et al., 2005). The relation 
between the presence of surfactin-like lipopeptides and/or other toxic factors and the risk of illness in 
human has not yet been established. 
In  the  absence  of  animal  models  shown  to  be  able  to  distinguish  hazardous  from  non-hazardous 
strains, the FEEDAP Panel relies on the use of in vitro cell-based methods to detect evidence of a 
cytotoxic effect. Such tests should be made with culture supernatants since the concentration of cells 
obtained in a broth culture would always exceed that found in animal food products.  
Accordingly, the following is recommended for the assessment of non-B. cereus group species:  
A  cytotoxicity  test  made  preferably  with  Vero  cells  or  other  epithelial  cell  lines  using  culture 
supernatant following the protocol described in the Appendix. Detection based on 
14C-leucine uptake 
is described but the use of other methods such as those based on lactate dehydrogenase release or 
propidium iodide uptake could be used as an alternative (Fagerlund et al., 2008).  
If the strain proves to be cytotoxic it is not recommended for use.   
The FEEDAP Panel recognises that the underlying cause of the rare outbreaks of food poisoning 
attributed to non-B. cereus species is currently poorly understood. Accordingly, the Panel would be 
open to alternative approaches to establish the safety of these Bacillus strains. 
3.3.  Assessment of species belonging to the Bacillus cereus group 
A review of the virulence factors involved in the gastro-intestinal infections caused by B. cereus can 
be found in Stenfors-Arnesen et al. (2008):  
  The role of hemolysin BL (Hbl) and of the non-hemolytic enterotoxin (Nhe) in diarrhoeal 
outbreaks has been confirmed (Stenfors-Arnesen et al., 2008). In particular the mode of 
action of Nhe on the cell membranes has been described (Lindbäck et al., 2010). Genes 
coding for Nhe, unlike those coding for Hbl, are present in most, if not all, strains of B. 
cereus (Guinebretière et al., 2010, Fagerlund et al., 2007) and the amount of Nhe produced 
at 32 °C by B. cereus strains was correlated with their cytotoxic activities (Moravek et al., 
2006). 
  The toxin previously named ‘Enterotoxin K’ (now cytotoxin K) has been characterised as a 
beta-barrel cytotoxin now called CytK (Lund et al., 2000). Two forms are distinguished 
(Fagerlund et al., 2004), CytK1 being more cytotoxic than CytK2. 
  Enterotoxin T has now been identified as the result of a cloning artefact (Hansen et al., 
2003) and should no longer be considered as a virulence factor. 
  Enterotoxin FM has been identified as an endopeptidase (Tran et al., 2010) which does not 
show direct toxic activity on epithelial cells. 
  Emetic toxin (cereulide) is still the only toxin identified in B. cereus causing the emetic 
disease. Its potent toxic effect on liver cells and various mammalian cell lines has been 
shown (Andersson et al., 2007). Fatal or very severe B. cereus emetic outbreaks have been 
reported since 2000 (Shiota et al., 2010; Posfay-Barbe et al., 2008; Dierick et al., 2005). 
The  non-ribosomal  peptide  synthase  producing  cereulide  has  been  identified  (Ehling-
Schulz et al., 2005) and characterised (Magarvey et al., 2006).  
Other factors produced by B. cereus with various toxic activities have been characterised (Hemolysin 
II and several metalloproteases) but there is no evidence so far of their implication in gastro-intestinal Guidance on Bacillus safety 
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diseases (Cadot et al., 2010). The toxic effect some of them show on macrophages may rather indicate 
a role in clinical infections. 
In summary, diarrhoeal disorders produced by B. cereus result from the production of toxins Nhe, Hbl 
and CytK, alone or in combination in the intestine (Table 1). The emetic disease results from the 
production of cereulide by B. cereus cells in the food. 
Table 1:   Bacillus cereus toxins which can be considered as the causative agents of gastro-intestinal 
diseases (Stenfors-Arnesen et al., 2008) 
Toxin  Genes/operons  Nature  Foodborne 
infection/intoxication 
Nhe (non hemolytic enterotoxin)  nhe  Protein (three components)  diarrhoeal 
Hbl (hemolysin BL)  hbl   Protein (three components*)  diarrhoeal 
CytK (cytotoxin K)  cytK  Protein  diarrhoeal 
Cereulide  ces  Cyclic peptide  emetic 
* The production of a fourth component, whose role has not been elucidated, was shown by Clair et al., 2010. 
In principle, the selection of strains belonging to the B. cereus taxonomic group for direct use in 
animal production is considered inadvisable.  
If, however, they are proposed for use then the full genome (including chromosome and plasmids) 
should be sequenced and bioinformatic analysis made to search for genes coding for enterotoxins and 
cereulide synthase (Table 1). If there is evidence of homology, the non-functionality of the genes (e.g., 
mutation, deletion) should be demonstrated. 
Strains harbouring a toxigenic potential should not be used as feed additives. 
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APPENDIX 
Recommended procedure for the detection of cytotoxicity using epithelial cell lines 
1.  Preparation of test substance 
 
Bacterial cells should be grown in brain heart infusion broth (BHI) at 30 °C and harvested after 6 h 
when it is anticipated that cells will have reached a density of at least 10
8 CFU/mL. Cells should be 
removed by centrifugation at room temperature. Toxicity is determined using 100 μL of supernatant in 
the Vero cells assay. 
2.  Cell assay 
 
Vero cells are grown in MEM medium supplemented with 5 % foetal calf serum. Cells are seeded into 
24-well plates two-three days before testing. Before use, check that the growth of the Vero cells is 
confluent. If so, remove the medium and wash the cells once with 1 mL preheated (37 ºC) MEM 
medium.   
 
  Add 1 mL preheated (37 ºC) low-leucine medium to each well and then add the  test 
substance (1-100 µL of Bacillus supernatant), incubate the cells for 2 hours at 37 ºC. 
  Remove  the  low-leucine  medium  with  the  toxin,  wash  each  well  once  with  1  mL 
preheated (37 ºC) low-leucine medium. Mix 8 mL preheated low-leucine medium with 16 
µL 
14C-leucine and add 300 µL of this mixture to each well, incubate the cells for 1 hour 
at 37 ºC. 
  Remove the radioactive medium and add 1 mL 5 % trichloroacetic acid (TCA) to each 
well, incubate at room temperature for 10 minutes. Remove TCA, and wash the wells 
twice with 1 mL of 5 % TCA. 
  After removing TCA, add 300 µL 0.1 M KOH and incubate at room temperature for 10 
minutes. Transfer the content of each well to liquid scintillation tubes with 2 mL of liquid 
scintillation  cocktail.  Vortex  the  tubes,  and  count  the  radioactivity  in  a  scintillation 
counter for 1 minute. 
  Percentage  inhibition  of  protein  synthesis  is  calculated  using  the  following  formula: 
((Neg. ctrl  – sample)/Neg. ctrl) × 100; the negative control is Vero cells from wells 
without addition of sample. Above 20 % inhibition is considered to indicate cytotoxicity. 
For the alternative method with propidium iodide uptake or lactate dehydrogenase, values above 20 % 
of the fluorescence/absorbance obtained from the positive control (usually detergent treated cells) are 
considered to indicate cytotoxicity.   
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